S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
66,000% upside on tiny biotech? (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
66,000% upside on tiny biotech? (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
66,000% upside on tiny biotech? (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
66,000% upside on tiny biotech? (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double

Aptose Biosciences (APTO) News Today

$1.95
0.00 (0.00%)
(As of 02/20/2024 ET)
SourceHeadline
finance.yahoo.com logoThis Aptose Biosciences Insider Increased Their Holding In The Last Year
finance.yahoo.com - January 29 at 8:49 AM
marketwatch.com logoAptose Biosciences Shares Drop 11% After Private, Public Offerings
marketwatch.com - January 26 at 6:27 PM
markets.businessinsider.com logoAptose Prices Offering Of About 4.91 Mln Shares At $1.71/Share, $4 Private Placement With Hanmi
markets.businessinsider.com - January 26 at 6:27 PM
finance.yahoo.com logoAptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
finance.yahoo.com - January 26 at 6:27 PM
investorplace.com logoWhy Is Aptose Biosciences (APTO) Stock Down Today?
investorplace.com - January 26 at 10:43 AM
benzinga.com logoAptose Biosciences Stock (NASDAQ:APTO), Guidance and Forecast
benzinga.com - December 21 at 1:08 AM
morningstar.com logoAptose Biosciences Inc APTO
morningstar.com - December 5 at 10:43 PM
msn.com logoAptose Biosciences files to sell ordinary shares, warrants
msn.com - December 4 at 10:00 AM
finanznachrichten.de logoAptose Biosciences, Inc.: Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
finanznachrichten.de - December 1 at 7:47 AM
seekingalpha.com logoAptose Biosciences Inc. (APTO) Q3 2023 Earnings Call Transcript
seekingalpha.com - November 12 at 7:59 PM
benzinga.com logoAptose Biosciences Stock (NASDAQ:APTO) Earnings Dates and Earning Calls
benzinga.com - November 11 at 8:49 PM
benzinga.com logoAptose Biosciences: Q3 Earnings Insights
benzinga.com - November 10 at 11:13 PM
markets.businessinsider.com logoPromising Financial Performance and Clinical Developments Bolster Aptose Biosciences’ Buy Rating: An Analysis by Joseph Pantginis
markets.businessinsider.com - November 10 at 11:13 PM
msn.com logoAptose Biosciences GAAP EPS of -$1.76 beats by $0.22
msn.com - November 9 at 8:40 PM
markets.businessinsider.com logoOppenheimer Reaffirms Their Buy Rating on Aptose Biosciences (APTO)
markets.businessinsider.com - November 1 at 5:32 AM
markets.businessinsider.com logoPromising Trial Data and Expansion Plans Boost Confidence in Aptose Biosciences: An Analysis of John Newman’s Buy Rating
markets.businessinsider.com - November 1 at 5:32 AM
finance.yahoo.com logoAptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib
finance.yahoo.com - October 30 at 10:18 AM
finance.yahoo.com logoAptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference
finance.yahoo.com - October 16 at 8:22 AM
theglobeandmail.com logoAptose Biosciences: Bottom 25 Performing Stocks Year-to-Date on TSX (APS)
theglobeandmail.com - October 12 at 5:32 PM
finance.yahoo.com logoCompanies Like Aptose Biosciences (TSE:APS) Could Be Quite Risky
finance.yahoo.com - September 8 at 3:54 PM
finance.yahoo.com logoHANMI FILES EARLY WARNING REPORT IN RESPECT OF APTOSE BIOSCIENCES INC.
finance.yahoo.com - September 7 at 6:50 PM
markets.businessinsider.com logoExpert Ratings for Aptose Biosciences
markets.businessinsider.com - September 7 at 6:50 PM
marketbeat.com logoShort Interest in Aptose Biosciences Inc. (NASDAQ:APTO) Declines By 12.8%
marketbeat.com - August 29 at 4:03 AM
finance.yahoo.com logoAptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - August 24 at 10:00 AM
theglobeandmail.com logoClosing Bell: Aptose Biosciences Inc down on Tuesday (APS)
theglobeandmail.com - August 23 at 6:59 PM
fool.com logoAptose Biosciences (NASDAQ: APTO)
fool.com - August 18 at 2:01 AM
markets.businessinsider.com logoRBC Capital Maintains Outperform Rating for Aptose Biosciences: Here's What You Need To Know
markets.businessinsider.com - August 11 at 7:33 PM
marketbeat.com logoRoyal Bank of Canada Cuts Aptose Biosciences (NASDAQ:APTO) Price Target to $23.00
marketbeat.com - August 11 at 2:23 PM
marketbeat.com logoAptose Biosciences Inc. (NASDAQ:APTO) Receives Consensus Rating of "Buy" from Analysts
marketbeat.com - August 11 at 10:49 AM
msn.com logoAptose Biosciences GAAP EPS of -$2.27 misses by $0.34
msn.com - August 11 at 3:19 AM
msn.com logoAptose Biosciences (APTO) Price Target Increased by 1614.75% to 62.90
msn.com - August 2 at 5:02 PM
finance.yahoo.com logoAptose to Report Second Quarter 2023 Financial Results and Hold Conference Call on Thursday, August 10, 2023
finance.yahoo.com - July 28 at 2:05 AM
finance.yahoo.com logoAPTO - Aptose Biosciences Inc.
finance.yahoo.com - June 27 at 11:27 PM
finance.yahoo.com logoAptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
finance.yahoo.com - June 26 at 6:09 PM
marketwatch.com logoAptose Shares Up 11% After Study Presentation, Analysts' Target Boosts
marketwatch.com - June 12 at 7:46 PM
benzinga.com logoOppenheimer Maintains Outperform on Aptose Biosciences, Raises Price Target to $50
benzinga.com - June 12 at 2:46 PM
benzinga.com logoAptose Biosciences shares are trading higher after multiple firms raised their respective price targets.
benzinga.com - June 12 at 2:46 PM
markets.businessinsider.com logoJonesTrading Keeps Their Buy Rating on Aptose Biosciences (APTO)
markets.businessinsider.com - June 10 at 8:43 PM
msn.com logoAptose Biosciences updates on reverse stock split
msn.com - June 5 at 10:04 AM
finanznachrichten.de logoAptose Biosciences, Inc.: Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
finanznachrichten.de - May 24 at 1:37 PM
marketwatch.com logoCaspase 3 Market Business Overview and Growth Forecast by 2030
marketwatch.com - May 17 at 7:16 AM
theglobeandmail.com logoClosing Bell: Aptose Biosciences Inc down on Friday (APS)
theglobeandmail.com - May 13 at 12:50 AM
msn.com logoAptose Biosciences GAAP EPS of -$0.15 misses by $0.03
msn.com - May 9 at 3:33 PM
markets.businessinsider.com logoAnalyst Expectations for Aptose Biosciences's Future
markets.businessinsider.com - May 9 at 3:33 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Aptose Biosciences (APTO)
markets.businessinsider.com - May 9 at 10:33 AM
marketwatch.com logoDiffuse Large B Cell Lymphoma Drug Market Outlook by 2031
marketwatch.com - April 28 at 8:15 AM
theglobeandmail.com logoClosing Bell: Aptose Biosciences Inc down on Monday (APS)
theglobeandmail.com - April 25 at 9:52 AM
finance.yahoo.com logoAptose to Report First Quarter 2023 Financial Results and Hold Conference Call on Monday, May 8, 2023
finance.yahoo.com - April 24 at 9:19 AM
theglobeandmail.com logoClosing Bell: Aptose Biosciences Inc up on Tuesday (APS)
theglobeandmail.com - April 19 at 10:25 AM
benzinga.com logoAptose to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference
benzinga.com - April 12 at 6:06 PM
Get Aptose Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for APTO and its competitors with MarketBeat's FREE daily newsletter.



APTO Media Mentions By Week

APTO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APTO
News Sentiment

0.00

0.53

Average
Medical
News Sentiment

APTO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APTO Articles
This Week

0

1

APTO Articles
Average Week

Get Aptose Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for APTO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:APTO) was last updated on 2/21/2024 by MarketBeat.com Staff